BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
cell-cell adhesion
,
HIV infection
,
Leukocyte
,
Amniocentesis
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
platelet derived growth factor receptor alpha
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Detection of FIP1L1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosi…
The Relationship of Clinicopathological Findings and PDGFR-β Expression With Tumor Recurrence in Gas…
Characterizing the role of Pdgfra in calvarial development.
PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
Association of PDGFRA polymorphisms with the risk of corneal astigmatism in a Japanese population.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable K…
A Study of Olaratumab (IMC-3G3) in Prostate Cancer
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastat…
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ